Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by LettinPoniesRunon Feb 13, 2017 12:50pm
303 Views
Post# 25837928

Mettrum, Organigram issues

Mettrum, Organigram issues
Mettrum Health Corp (C:MT) 
Shares Issued 48,044,087
Monday February 13 2017 - In the News
Also Organigram Holdings Inc (C:OGI) In the News
The Globe and Mail reports in its Saturday, Feb. 11, edition that University of Wisconsin-Madison toxicologist Warren Porter says patients are not being given accurate information on the risks associated with a banned pesticide thousands of people may have consumed. The Globe's Grant Robertson writes that Mettrum and Organigram have sent messages to customers over the past two months informing them that products they had purchased were being recalled because of the presence of banned pesticides, including myclobutanil. A letter to Mettrum's clients said, "Rest assured, this material is not deemed to present a health risk." Organigram informed clients that "the probability of serious adverse health consequences is remote," while Health Canada has referred to the amounts of banned pesticide detected as "trace amounts" that are "low risk." Dr. Porter says: "Ultra-low doses can have all kinds of biological effects, especially over longer periods of exposure. So when these companies say 'Oh, there's no problem,' the first thing I would ask them is have you looked at the effects on the nervous system, the endocrine system, the immune system and epigenetics?"
 
Bullboard Posts